-+ 0.00%
-+ 0.00%
-+ 0.00%

Mineralys Therapeutics CMO David Malcom Rodman disposes of USD 559,234 in common shares

PUBT·07/16/2026 00:58:48
Listen to the news
Mineralys Therapeutics CMO David Malcom Rodman disposes of USD 559,234 in common shares
  • Mineralys Therapeutics Chief Medical Officer Rodman David Malcom cut his stake to 51,384 shares following option exercises and stock sales.
  • Malcom exercised stock options for 14,058 shares on July 13 at prices from $1.08 to $14.25.
  • He sold 20,407 shares on July 13-15 at weighted-average prices of $27.58 and $26.61.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mineralys Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001933414-26-000099), on July 15, 2026, and is solely responsible for the information contained therein.